Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • Article
  • npj Digital Medicine

Quantifying the Use of Connected Digital Products in Clinical Research

By: Caroline Marra, Jacqueline L. Chen, Andrea Coravos and Ariel D. Stern
  • Format:Electronic
ShareBar

Abstract

Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g., products that capture physiological and behavioral metrics) in formal clinical research. Using 18 years of data from ClinicalTrials.gov, we document substantial growth in the use of connected digital products in clinical trials (~34% CAGR) and show that these products have been used across all phases of research and by a diverse group of trial sponsors. We identify four distinct use cases for how such connected products have been integrated within clinical trial design and suggest implications for various stakeholders engaging in clinical research.

Keywords

Connected Digital Products; Clinical Trials; Health Testing And Trials; Technology; Research

Citation

Marra, Caroline, Jacqueline L. Chen, Andrea Coravos, and Ariel D. Stern. "Quantifying the Use of Connected Digital Products in Clinical Research." Art. 50. npj Digital Medicine 3 (2020).
  • Read Now

About The Author

Ariel D. Stern

Technology and Operations Management
→More Publications

More from the Authors

    • January–February 2021
    • American Journal of Therapeutics

    Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses

    By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
    • Harvard Business Review (website)

    Want to See the Future of Digital Health Tools? Look to Germany

    By: Ariel Dora Stern, Henrik Matthies, Julia Hagen, Jan B. Brönneke and Jörg F. Debatin
    • September–October 2020
    • NEJM Catalyst Innovations in Care Delivery

    The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

    By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
More from the Authors
  • Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
  • Want to See the Future of Digital Health Tools? Look to Germany By: Ariel Dora Stern, Henrik Matthies, Julia Hagen, Jan B. Brönneke and Jörg F. Debatin
  • The Past, Present, and (Near) Future of Gene Therapy and Gene Editing By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Digital Accessibility
Copyright © President & Fellows of Harvard College